Streetbeat News

Price Targets

VICI

VICI Props (NYSE:VICI) received 8 analyst ratings in the last quarter, with an average 12-month price target of $34.88, a high of $38.00, and a low of $31.00. The current average price target represents a 2.43% decrease from the previous average of $35.75. The ratings included 1 bullish, 6 somewhat bullish, and 1 indifferent, with no bearish ratings. Analysts typically review stocks quarterly or after major company updates, considering factors like future earnings and revenue potential.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

HLMN

Over the past 3 months, 4 Wall Street analysts have provided ratings for Hillman Solutions Corp (NASDAQ:HLMN), with an average price target of $10.12, representing an upside from the current price of $7.69. The current average target has decreased by 12% from the previous target of $11.50. The ratings include 1 bullish, 2 somewhat bullish, and 1 indifferent, with no bearish ratings. Analysts typically review stocks quarterly and may adjust their predictions based on various factors, including company performance and market conditions.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

VZIO

VIZIO Holding (NYSE:VZIO) has received 5 analyst ratings in the past quarter, with 3 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for VIZIO is $9.8, which is a 10.91% decrease from the previous target of $11.00. Analysts use various data sources to provide ratings and forecasts for stocks.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

DHI

Analysts have provided mixed ratings for D.R. Horton (NYSE:DHI) in the last quarter, with 1 bullish, 3 somewhat bullish, 2 indifferent, and 1 somewhat bearish rating. The average 12-month price target among 7 analysts is $135.71, with a high of $166.00 and a low of $116.00. This target has decreased by 3.98% from the previous average of $141.33. Analyst ratings are based on information from company calls, financial statements, and insider conversations, and include predictions on earnings, revenue, and growth, though they are subjective and not infallible.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

HARP

Harpoon Therapeutics (NASDAQ:HARP) received three bullish analyst ratings in the last quarter with an average price target of $19.33, representing significant upside from the current price of $8.55. This target is a 42.3% decrease from the previous target of $33.50. Analysts base their ratings on various data including company performance and insider conversations.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:00 pm

JNJ

Wells Fargo analyst Larry Biegelsen downgraded Johnson & Johnson (JNJ) from Overweight to Equal-Weight and reduced the price target from $170 to $163.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:52 am

JCI

Barclays analyst Julian Mitchell has maintained an Equal-Weight rating on Johnson Controls International (JCI) but has reduced the price target from $64 to $60.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:52 am

TMHC

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Taylor Morrison Home (NYSE:TMHC) and increased the price target from $47 to $55.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:51 am

SKY

Barclays analyst Matthew Bouley has maintained an Equal-Weight rating on Skyline Champion (NYSE:SKY) and increased the price target from $61 to $69.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:50 am

TREX

Barclays analyst Matthew Bouley has downgraded Trex Co (NYSE:TREX), a manufacturer of wood-alternative decking products, from Equal-Weight to Underweight. However, he has increased the price target for the company's stock from $66 to $74.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:49 am